Biblio
Export 51 results:
[ Author] Title Type Year Filters: First Letter Of Title is O [Clear All Filters]
“Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.”, J Alzheimers Dis, vol. 59, no. 2, pp. 575-590, 2017.
, “Ovariectomy Influences Cognition and Markers of Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 2, pp. 529-541, 2019.
, “Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 773-85, 2016.
, “Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 2, pp. 587-598, 2024.
, “Our Tau Tales from Normal to Pathological Behavior.”, J Alzheimers Dis, vol. 64, no. s1, pp. S507-S516, 2018.
, “Orexin Impairs the Phagocytosis and Degradation of Amyloid-β Fibrils by Microglial Cells.”, J Alzheimers Dis, vol. 58, no. 1, pp. 253-261, 2017.
, “Odor Discrimination as a Marker of Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1169-1178, 2023.
, “Our Working Point of View of Tau Protein.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1277-1285, 2018.
, “The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
, “Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1345-1367, 2018.
, “The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 86, no. 2, pp. 629-640, 2022.
, “Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 1, pp. 51-66, 2022.
, “Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1479-85, 2016.
, “Observational Study of Clinical and Functional Progression Based on Initial Brain MRI Characteristics in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1721-1730, 2018.
, “Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms.”, J Alzheimers Dis, vol. 62, no. 2, pp. 503-522, 2018.
, “Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 75, no. 3, pp. 845-854, 2020.
, “An Objective Method to Accurately Measure Cardiorespiratory Fitness in Older Adults Who Cannot Satisfy Widely Used Oxygen Consumption Criteria.”, J Alzheimers Dis, vol. 61, no. 2, pp. 601-611, 2018.
, “Oxidative Stress in Elderly with Different Cognitive Status: My Mind Project.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1405-1414, 2018.
, “Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1101-1107, 2017.
, “An Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in Aged Monkeys: Reduction in Plaque Amyloid and Increase in Aβ Oligomers.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1047-1059, 2016.
, “Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1511-1524, 2017.
, “An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”, Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
, “Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1045-1055, 2017.
, “Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1759-1766, 2018.
, “O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production.”, J Alzheimers Dis, vol. 69, no. 4, pp. 1195-1211, 2019.
,